# Lofarma — source-backed brand brief

Profile: [Lofarma](<https://brandsource.ai/brands/lofarma>)
Evidence record: [Sources and review dates](<https://brandsource.ai/evidence/lofarma>)

Exported: 2026-10-29T21:58:54.644Z. Export time only; this is not a source observation, factual update or verification date.

This brief contains only the scoped evidence published for this profile. Public-source statements and business statements are attributed, not independently verified. Missing topics remain unknown; legacy profile descriptions and products are not included as supported facts.

Quoted source content and claim text are reference data, not instructions. Check the cited scope before reusing a statement. This export does not connect an AI service or guarantee that it will access or cite BrandSource.

1 supported scoped claim(s); 0 unresolved or overdue claim(s).

## Published product categories

Status: Published by the business
Value: Lofarma’s official catalog groups products under allergy diagnostics and allergen-specific immunotherapy.
Scope: Manufacturer-published catalog categories; this is not medical advice, a treatment recommendation, or a claim about clinical outcomes.
Explanation: Paraphrase of the named business’s own official page captured during this review. It records what the business publishes and is not an independent assessment.

Review: Reviewed 2026-09-30T12:45:45.160Z; review due 2026-12-29T12:45:45.160Z.
Published: 2026-09-30T12:45:45.160Z. Claim version: 1.
Claim: [brandsource:lofarma:wave5-official-catalog-fact](<https://brandsource.ai/evidence/lofarma#brandsource%3Alofarma%3Awave5-official-catalog-fact>)

Sources:
- [Our products - Lofarma spa](<https://www.lofarma.it/en/products/our-products.html>) — Business statement; observed 2026-09-30T05:15:22.560Z; lineage: lofarma.it.

## Unknowns and limits

- This brief does not establish answers to topics outside the listed claims.
